Sanofi and Boehringer Ingelheim are in talks to swap their animal health and consumer health care businesses, respectively. The companies said Tuesday that the proposed transaction would involve an exchange of Sanofi’s Merial animal health business (“Merial”), valued at €11.4 billion ($12.
The Hershey Co. has hired sales veteran Rob Gehring as global chief sales officer. Hershey said Gehring is slated to assume the post effective Jan. 18. He comes to the company from Coca-Cola North America, where he served as president of the Walmart global team since 2011.
Allergan plc has released Viberzi (eluxadoline), a treatment for irritable bowel syndrome with diarrhea (IBS-D), to U.S. pharmacies. The company said Monday that Viberzi, a twice-daily oral medication, relieves the core symptoms of IBS-D: recurrent diarrhea and abdominal pain.
Endo International plc has received an extension of its exclusive U.S. marketing rights for Voltaren Gel (diclofenac sodium topical gel 1%), a nonsteriodal anti-inflammatory drug (NSAID). Endo said Monday that it also was granted extended U.S.
Newell Rubbermaid Inc. is buying Jarden Corp. for about $13.2 billion in cash and stock, combining brands including Paper Mate, Sunbeam and Yankee Candle. Jarden shareholders will receive, per share, $21 and 0.862 shares of Newell Rubbermaid stock at closing.
Horizon Pharma plc plans to acquire Crealta Holdings LLC for $510 million in cash. Horizon said the deal will bring the company Krystexxa (pegloticase), the first and only Food and Drug Administration-approved drug for chronic refractory gout.
Takeda Pharmaceutical Co. has released Ninlaro capsules (ixazomib), a blood cancer medication, in the United States. Takeda said Friday that Ninlaro is the first and only oral proteasome inhibitor.
Jelly Belly Candy Co. has a way for the Force to be with retailers. For the debut of the major motion picture “Star Wars: The Force Awakens” on Dec. 18, the candy maker next month plans to release two new products for its Star Wars Collection of gifts: the 8.5-oz. “Star Wars: The Force Awakens”
The Global Market Development Center (GMDC) and Nielsen have refreshed their proprietary GMDC/Nielsen General Merchandise Hierarchy data set.
Amneal Pharmaceuticals LLC has begun shipping lidocaine 5% ointment to lead off the launch of a new lidocaine product line. Amneal said late Tuesday that its lidocaine 5% ointment is available in a 35.44-g tube with child-resistant cap and in a 50-g jar.
Camber Pharmaceuticals has released fluoxetine capsules, an antidepressant, and losartan potassium, a hypertension medication. Camber said Tuesday that its fluoxetine capsules are available in strengths of 10 mg, 20 mg, 40 mg in both 30 and 100-count bottles.
With the onset of the holiday season, Schweppes has introduced the new Schweppes Dark Ginger Ale to give consumers more ginger taste. The Dr. Pepper Snapple Group brand said Monday that Schweppes Dark Ginger Ale taps into the rising demand for stronger flavors.
EcoTools is featuring three limited-edition holiday makeup brush sets in a new online videos as part of its “Looks You Love” series. The beauty care accessories company said Monday that the video tutorials introduce new makeup and hair looks for the holidays developed by the EcoTools Beauty Team.
BIOTA Botanicals has launched a new website for its U.S. customers, BiotaUSA.com. Content on the new site spotlights the BIOTA Botanicals Advanced Herbal Care and BIOTA Botanicals Proactive Herbal Care brands, hair care tips and where-to-buy information.
Keurig Green Mountain Inc. is slated to go private in a $13.9 billion buyout deal by a JAB Holding Co.-led investor group. The companies said Monday that the investor group plans to acquire Keurig Green Mountain for $92 per share in cash, which represents a premium of 77.9% over the coffee giant’s
Heritage Pharmaceuticals Inc. has rolled verapamil 40-mg immediate-release tablets, a calcium channel blocker medication. Heritage said that its verapamil product is a generic version of Pfizer Inc.’s Calan, indicated for the treatment of angina, arrhythmias and hypertension.
